The U.S. House Judiciary Committee voted Sept. 30 to approve a fourth bill aimed at tackling high drug prices, approving a measure that would make it easier for biosimilar drugs – cheaper versions of expensive biotech drugs – to come to market.
The U.S. House Judiciary Committee voted on Sept. 29 to approve three bills to stop practices drugmakers use to raise prices and fend off competition, including a bill to ban the tactic of paying generic companies to delay bringing cheaper versions of their medicines to market.
Bausch Health Companies Inc. agreed to pay $300 million to settle an antitrust lawsuit accusing it of illegally maintaining a monopoly on the diabetes drug Glumetza, enabling a nearly 800 percent price hike in 2015.
Dr. Reddy’s Laboratories Ltd. along with the company’s subsidiaries announced that Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules, was approved by Health Canada and launched in the Canadian market.
India’s drug regulator granted emergency use approval for Zydus Cadila’s Covid-19 vaccine, the world’s first DNA shot against the coronavirus, in adults and children aged 12 years and older.
PharmaLive talked to Milan Kalawadia – Senior Vice President, Head of US Commercial Operations for Dr. Reddy’s Laboratories – about facing challenges from the COVID-19 pandemic; obstacles going forward for generic drug companies; customer relationships; and other industry-related topics.
Idorsia is launching a late-stage trial of the experimental heart-attack drug selatogrel that the Swiss company hopes will become what it describes as akin to an “EpiPen” for people at risk of acute myocardial infarction (AMI).
The U.S. Supreme Court on June 21 rejected a bid by an Amarin Corp. subsidiary to revive patents on the company’s heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals Plc and Dr. Reddy’s Laboratories Ltd.
Russia’s Supreme Court on May 27 rejected a lawsuit from Gilead Sciences that challenged a Russian government decision to let a Russian firm develop and market the anti-Covid-19 drug remdesivir without the U.S. company ‘s consent.
New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. The data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.